Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait
Affiliations
Affiliations
- Genetics and Bioinformatics department, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Division of Neurology, Department of Medicine, Amiri Hospital, Mirqab 13041, Kuwait.
- Human Genetics Unit, Department of Pathology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait. Electronic address: rabeah@hsc.edu.kw.
Abstract
Background: Leptin association with Multiple sclerosis (MS) pathogenesis and MS related clinical characteristics is inconsistent. Here, we investigated whether two common variants in leptin (LEP) and leptin receptor (LEPR) genes influence MS risk and leptin levels in MS patients.
Methods: In a case-control study including 169 MS patients and 100 controls we examined the association of leptin in MS. Blood samples were used for DNA extraction and plasma retrieval. Taqman genotyping assays were used for LEP rs7799039 and LEPR rs1137101 genotyping, and enzyme-linked immunosorbent assay for plasma leptin level.
Results: Leptin levels were significantly lower in MS patients compared to controls (β = 0.157, 95%CI: 0.033-0.26, p = 0.012). LEP rs7799039AA associated with MS risk (OR: 2.52; 95%CI: 1.35-4.67, p = 0.003). None of the assessed markers associated with MS disability, severity or response to treatment.
Conclusion: LEP rs7799039AA is a risk factor for MS in our Kuwaiti population, and leptin levels are lower in MS patients compared to healthy controls. Our findings suggest future studies must consider all factors influencing leptin levels to resolve its controversial involvement in MS pathogenesis or progression.
Keywords: Leptin; Leptin receptor; Multiple sclerosis; Polymorphism.
Similar articles
Kolić I, Stojković L, Stankovic A, Stefanović M, Dinčić E, Zivkovic M.Gene. 2021 Mar 30;774:145422. doi: 10.1016/j.gene.2021.145422. Epub 2021 Jan 12.PMID: 33450350
Bains V, Kaur H, Badaruddoza B.Gene. 2020 Sep 5;754:144846. doi: 10.1016/j.gene.2020.144846. Epub 2020 Jun 5.PMID: 32512158
Farrokhi M, Dabirzadeh M, Fadaee E, Beni AA, Saadatpour Z, Rezaei A, Heidari Z.Immunol Invest. 2016 May;45(4):328-35. doi: 10.3109/08820139.2016.1157811. Epub 2016 Apr 22.PMID: 27105071
Gu F, Kraft P, Rice M, Michels KB.Breast Cancer Res Treat. 2012 Jan;131(1):17-25. doi: 10.1007/s10549-011-1778-6. Epub 2011 Sep 25.PMID: 21947707 Free PMC article. Review.
LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
Lin HY, Shi H, Li CY, Chen QC, Huang TB, Liu PC, Lou LM.J BUON. 2015 Jan-Feb;20(1):261-8.PMID: 25778326 Review.
Cited by
Adipokines in multiple sclerosis patients are related to clinical and radiological measures.
Loonstra FC, Falize KF, de Ruiter LRJ, Schoonheim MM, Strijbis EMM, Killestein J, de Vries HE, Uitdehaag BMJ, Rijnsburger M.J Neurol. 2023 Apr;270(4):2018-2030. doi: 10.1007/s00415-022-11519-8. Epub 2022 Dec 23.PMID: 36562851 Free PMC article.
References
https://pubmed.ncbi.nlm.nih.gov/